Dengue Fever
📧 Sign up to get email alerts when something new happens for Dengue Fever.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: A Study to Evaluate V181 Dengue Vaccine in Healthy Participants 2 to 17 Years of Age (V181-005/MOBILIZE-1) [Phase 3]
A Phase 3 clinical trial to evaluate the V181 dengue vaccine in healthy participants aged 2 to 17, currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Investigating Vector-Borne Determinants of Aedes Transmitted Arboviral Infections in Cambodia: An Observational Longitudinal Cohort Study in Children
A completed observational longitudinal cohort study in Cambodian children examining determinants of Aedes-transmitted arboviral infections, …
-
CLINICAL_TRIALS trial_result · 2026-04-09Clinical Trial Update: Xpert® Tropical Fever Test on GeneXpert® Edge X System
A clinical trial update indicates Cepheid is enrolling by invitation to evaluate the Xpert Tropical Fever Test on the GeneXpert Edge X Syste…
-
CLINICAL_TRIALS trial_result · 2026-03-31Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of AV-1 Against Dengue Virus 3 (DENV-3) Infection [Phase 2]
A Phase 2 study evaluating the safety and efficacy of AV-1 against Dengue virus serotype 3 infection has completed in a controlled human inf…
-
CLINICAL_TRIALS trial_result · 2026-03-19Clinical Trial Update: Testing Combined IIT-SIT to Control Mosquito-Borne Diseases At Scale [NA]
This clinical trial update reports termination of a study evaluating combined IIT-SIT technology to control dengue fever, Zika virus disease…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-03-09Clinical Trial Update: Evaluation of the Protective Efficacy of TV003 or Previous Zika Infection Against Infection With ZIKV-SJRP Challenge Compared to DENV and ZIKV-naïve Controls Against Infection With ZIKV-SJRP Challenge [Phase 1]
Phase 1 clinical trial assessing whether TV003 vaccination or prior Zika exposure provides protection against ZIKV-SJRP challenge compared w…
-
CLINICAL_TRIALS trial_result · 2026-02-25Clinical Trial Update: Prediction of Infectious Diseases in LMICs Using Electronic Health Record Data
A completed clinical trial from Mahidol University evaluated using electronic health record data to predict infectious diseases in LMICs, fo…
-
CLINICAL_TRIALS trial_result · 2026-02-12Clinical Trial Update: A Study on a New Tetravalent Dengue Vaccine (TDV) Formulation in Healthy Adults [Phase 3]
Takeda's tetravalent dengue vaccine (TDV) is in a Phase 3 trial in healthy adults, with the study currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2026-02-03Clinical Trial Update: Characterizing Humoral Immune Response to Mosquito Bites [NA]
A completed University of Oxford clinical trial studied the humoral immune response to mosquito bites in the contexts of malaria and dengue …
-
CLINICAL_TRIALS trial_result · 2026-01-13Clinical Trial Update: The Effectiveness of the Board Game on Primary Healthcare Nurses' Knowledge, Attitudes, and Confidence in Dengue-related Practice [NA]
This ClinicalTrials.gov update reports a completed study by Taipei Medical University evaluating a board game to improve primary healthcare …
-
CLINICAL_TRIALS trial_result · 2025-12-30Clinical Trial Update: A Study of Dengue Tetravalent Vaccine (TDV) in Healthy Participants in Japan [Phase 2, Phase 3]
Takeda completed Phase 2 and Phase 3 trials of the Dengue Tetravalent Vaccine (TDV) in healthy participants in Japan.
-
CLINICAL_TRIALS trial_result · 2025-11-26Clinical Trial Update: A Study of Dengue Vaccine in Healthy Children, Teenagers and Adults in India [Phase 3]
Takeda's dengue vaccine TAK-003 was studied in a Phase 3 trial in healthy children, teenagers and adults in India, and the study has complet…
-
CLINICAL_TRIALS trial_result · 2025-11-25Clinical Trial Update: A Cluster-randomized Trial to EValuate the Efficacy of Wolbachia-InfecTed Aedes Aegypti Mosquitoes in Reducing the Incidence of Arboviral Infection in Brazil (EVITA Dengue) [NA]
This update reports the completion of a cluster-randomized trial in Brazil assessing whether releasing Wolbachia-infected Aedes aegypti mosq…
-
CLINICAL_TRIALS trial_result · 2025-10-03Clinical Trial Update: Evaluating Public Awareness and Preventive Actions for Dengue Fever in Sudan Amidst Ongoing Crises
This trial update reports a completed study evaluating public awareness and preventive actions for dengue fever in Sudan amid ongoing crises…
-
CLINICAL_TRIALS trial_result · 2025-09-15Clinical Trial Update: To Assess the Efficacy of Carica Papaya Leaf Extract in Improving Platelet Counts Among Pediatric Patients With Dengue-associated Thrombocytopenia [Phase 2]
Phase 2 clinical trial update evaluating Carica Papaya Leaf Extract for improving platelet counts in pediatric dengue-associated thrombocyto…
-
CLINICAL_TRIALS trial_result · 2025-08-08Clinical Trial Update: Surveillance of Suspected Dengue Cases for Access to Care for Subjects Identified as Seronegative or Undetermined Before Receiving CYD Dengue Vaccine in Previous Clinical Studies in Colombia
An ongoing surveillance update in Colombia assessing suspected dengue cases to ensure access to care for participants who were seronegative …
-
CLINICAL_TRIALS trial_result · 2025-06-26Clinical Trial Update: The Comparative Efficacy of Standard Treatment Plus Ribavirin vs Standard Treatment Alone in Preventing Clinically Significant Hemorrhage in Patients With Dengue Fever [Phase 3]
Phase 3 randomized trial evaluating whether adding ribavirin to standard dengue treatment reduces clinically significant hemorrhage compared…
-
CLINICAL_TRIALS trial_result · 2025-06-12Clinical Trial Update: Long-Term Safety and Antibody Persistence of TDV and the Impact of a Booster Dose [Phase 3]
Phase 3 study evaluating long-term safety and antibody persistence of the Takeda dengue vaccine (TDV) and the impact of a booster dose, with…
-
CLINICAL_TRIALS trial_result · 2025-05-09Clinical Trial Update: Safety and Immunogenicity of Three V181 Dengue Vaccine Potencies in Adults (V181-003) [Phase 2]
Phase 2 trial evaluating safety and immunogenicity of three potencies of the V181 dengue vaccine in adults; results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-04-25Clinical Trial Update: Effects of Carica Papaya Leaf Extract (CPLE) in the Outcome of Hospitalized Dengue Patients [Phase 1, Phase 2]
Phase 1/2 clinical trial update assessing the effects of Carica papaya leaf extract (CPLE) in hospitalized dengue patients; the study has be…
-
CLINICAL_TRIALS trial_result · 2025-04-24Clinical Trial Update: An Evaluation of Repeated Oral Doses of JNJ-64281802 Against DENV-3 Challenge [Phase 2]
Phase 2 trial evaluating repeated oral doses of JNJ-64281802 against Dengue virus serotype 3 has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2025-01-17Clinical Trial Update: Safety and Immunogenicity of the Dengue Virus Vaccine TV005 (TetraVax-DV TV005) in Healthy Adults, Adolescents, and Children in Dhaka, Bangladesh [Phase 2]
Phase 2 study assessing safety and immunogenicity of the dengue vaccine TV005 (TetraVax-DV TV005) in healthy adults, adolescents, and childr…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Cohort Event Monitoring for Dengvaxia®, CYD-TDV Dengue Vaccine
This document reports the completion of a cohort event monitoring study for Dengvaxia (CYD-TDV) dengue vaccine, describing safety observatio…
-
CLINICAL_TRIALS trial_result · 2024-07-19Clinical Trial Update: Safety and Immunogenicity of a Tetravalent Dengue Vaccine in HIV-Positive Adults [Phase 2]
Phase 2 trial evaluating safety and immunogenicity of a tetravalent dengue vaccine in HIV-positive adults; results completed and posted in J…
-
CLINICAL_TRIALS trial_result · 2024-05-23Clinical Trial Update: Population Immunity AgaiNst mosquitO-borne Diseases in Vanuatu [NA]
A clinical trial evaluating population immunity to multiple mosquito-borne diseases in Vanuatu has completed, covering Zika virus disease, d…